Consensus opinion on immune-mediated cytopenias after hematopoietic cell transplant for inherited metabolic disorders

Hematopoietic stem cell transplantation (HCT) has been increasingly used for patients with inherited metabolic disorders (IMD). Immune mediated cytopenias (IMCs) after HCT, manifesting as hemolytic anemia, thrombocytopenia, and/or neutropenia, are recognized as a significant complication in this pat...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Bone Marrow Transplant
Prif Awduron: Gupta, Ashish O., Jan Boelens, Jaap, Ebens, Christen L., Kurtzberg, Joanne, Lund, Troy C., Smith, Angela R., Wagner, John E., Wynn, Robert, Blazar, Bruce R., Orchard, Paul J.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Nature Publishing Group UK 2021
Pynciau:
Perspective
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8189901/
https://ncbi.nlm.nih.gov/pubmed/33441980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-020-01179-5
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg